| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/16/2002 | US6420357 Antitumor |
| 07/16/2002 | US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/16/2002 | US6420031 Organic light emitting devices; thin film of copper phthalocyanine capped with a film of low-power, radio frequency sputtered indium-tin-oxide; the cupc prevents damage to the underlying organic layers during the ito sputtering |
| 07/16/2002 | US6419897 Porphyrin compounds |
| 07/16/2002 | CA2205998C Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 07/16/2002 | CA2119511C Benzimidazole compounds, their use and preparation |
| 07/11/2002 | WO2002053570A1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2000075144A9 Peroxynitrite decomposition catalysts and methods of use thereof |
| 07/11/2002 | US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/11/2002 | US20020091118 Psychotherapeutic agents. |
| 07/11/2002 | US20020091117 Psychotherapeutic agents. |
| 07/11/2002 | US20020091116 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades |
| 07/11/2002 | US20020091113 Treatment of septic shock |
| 07/11/2002 | DE10100943A1 Production of a solution of pure triethylenediamine comprises evaporation from a mixture comprising a solvent or a diluent having a specified boiling point at normal pressure |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
| 07/10/2002 | EP1220672A1 Medicament for treatment of neuropathies |
| 07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
| 07/10/2002 | CN1357536A Linking molecule for selective metallation of nucleic acid and its application |
| 07/10/2002 | CN1087294C Novel compounds |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
| 07/09/2002 | US6417354 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/09/2002 | US6417217 Prolines as antimicrobial agents |
| 07/09/2002 | US6417189 Drugs with pyrazole ketone derivatives |
| 07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
| 07/09/2002 | US6417150 Comprising organotin(iv), organogermanium(iv), organopaltinum(iv), organopalladium(iv), organolead(iv) or organophosphorous(iii) phthalocyanine and napthalocyanines having q-band absorption maxima at greater than 660 nm |
| 07/09/2002 | CA2041224C Azatetracycle compounds |
| 07/04/2002 | WO2002051846A1 Apicidin-derivatives, their synthetic methods, and antitumor compositions containing the same |
| 07/04/2002 | WO2002051845A2 Triazolopyrimidines |
| 07/04/2002 | WO2002051844A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 07/04/2002 | WO2002051837A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051797A1 Novel functional peptide nucleic acid monomer and process for producing the same |
| 07/04/2002 | WO2002026742A3 PROCESS FOR THE PREPARATION OF 2-ALKOXY-6-TRIFLUOROMETHYL-N-([1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-2-YL)BENZENESULFONAMIDES |
| 07/04/2002 | WO2001044260A9 Novel purines |
| 07/04/2002 | US20020087009 Intermediates for (r)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a] imidazol-2-one |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | US20020086860 For treatment or prevention of disorders such as obsessive-compulsive disorder, depression, anxiety, schizophrenia |
| 07/04/2002 | CA2432654A1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/03/2002 | EP1219623A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 07/03/2002 | EP1219609A1 Aromatic nitrogenous six-membered ring compounds |
| 07/03/2002 | EP1219594A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 07/03/2002 | EP1218384A1 Tetracyclic benzimidazole derivatives and combinatorial libraries thereof |
| 07/03/2002 | EP1218383A2 Bicyclic imidazo-5-yl-amine derivatives |
| 07/03/2002 | EP1218382A2 Bicyclic imidazo-3-yl-amine derivatives |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218380A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 07/03/2002 | EP1218379A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218378A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218337A1 Synthesis of 3,5,7]-1h-imidazo 1,5-a]imidazol-2(3h)-one compounds |
| 07/03/2002 | EP1218008A2 New use of 1,2,4-triazolo[1,5-a]pyrimidines |
| 07/03/2002 | EP0973776B1 A process for the preparation of tetraazamacrocycles |
| 07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
| 07/03/2002 | CN1356329A Unsymmetric phthalocyanine derivative and its application in optical record medium |
| 07/02/2002 | USRE37781 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/02/2002 | US6414161 Chemical intermediate in preparation of small molecules that inhibit interaction of celluar adhesion molecules thereby treating or preventing inflammatory and immune cell-mediated disease |
| 07/02/2002 | US6414156 Efficent, notoxic process of making new key intermediate quaternary ammonium salts and 2-oxazolylalkyl sulfide derivatives and avoids the reaction of a-haloketones with an azide followed by reducing the resulting a-aminoketone |
| 07/02/2002 | US6414149 Treating diabetes, treating or preventing diabetic complications |
| 07/02/2002 | US6414144 Such as (2s)-(rel-7br,10ar)-2-methyl-1,2,3,4,8,9,10,10a-octahydro-7bh -cyclopenta(b)(1,4)diazepino(6,7,1-hi)indole; for treatment of obesity |
| 07/02/2002 | US6413982 4-substituted quinoline derivatives |
| 07/02/2002 | US6413981 Drug-resistant gram positive and gram negative bacteria; pneumonia; infections of upper and lower respiratory tract, skin, soft tissue, bones and joints |
| 07/02/2002 | US6413980 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 07/02/2002 | US6413972 5,8-dihydro-3-methyl-5-oxo-8-(1-oxo-1-phenyl-2-propyl)-2 -phenylimidazo(1,2-a)pyrimidine-6-carboxylic acid ethyl ester; gonadotropin-releasing hormone antagonizing activity; low toxicity; anticarcinogenic agent; contraceptive |
| 07/02/2002 | US6413971 Antiproliferative, -carcinogenic, -tumor and -diabetic agents; binding to or modulating the human kinase insert-domain-containing receptor (kdr) or the murine fetal liver kinase 1 (flk-1) receptor; vasculogenesis; angiogenesis |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413956 Substituted 4-oxo-quinoline-3-carboxamides |
| 07/02/2002 | US6413952 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal |
| 07/02/2002 | US6413924 Photobleaching compositions comprising mixed metallocyanines |
| 07/02/2002 | US6413656 Multilayer device containing doped emissive layer producing saturated red light; brighter display |
| 07/02/2002 | US6413655 Fluorescent materials and their use |
| 07/02/2002 | US6413495 X-ray intercepting metal complexes of chlorin derivatives |
| 07/02/2002 | US6413447 Photoconducting silicon complexes, liquid crystal materials, composition thereof, and elements using same |
| 07/02/2002 | CA2201604C Process for preparing n,n'-difluorodiazoniabicycloalkane salt, intermediate therefor, product and use of product |
| 06/27/2002 | WO2002050080A1 Small molecules useful in the treatment of inflammatory disease |
| 06/27/2002 | WO2002050079A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 06/27/2002 | WO2002050078A1 Novel substituted imidazotriazinones as pde ii-inhibitors |
| 06/27/2002 | WO2002050077A2 Triazolopyrimidines |
| 06/27/2002 | WO2002050076A2 Method for producing sulfonamide-substituted imidazotriazinones |
| 06/27/2002 | WO2002050075A1 Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002049651A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 06/27/2002 | WO2002026748A3 Metal complexes for use in medical and therapeutic applications |
| 06/27/2002 | WO2002024613A3 Resorcinol derivatives |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | US20020082441 Useful as an intermediate in preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases |
| 06/27/2002 | US20020082424 Alkylating an aryl halide with 1,3-dichloropropene and n-tetrabutylammonium iodide catalyst for forming vinyl chloride compound which is subjected to cyclization using tribuytyl tin hydride, catalyst and toluene as the solvent |
| 06/27/2002 | US20020082420 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
| 06/27/2002 | US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects |
| 06/27/2002 | US20020081626 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
| 06/27/2002 | DE10064105A1 Neue Substituierte Imidazotriazinone New Substituted imidazotriazinones |